LDS/Medical Tests/Triglycerides, Serum

Triglycerides, Serum

Triglycerides are the chemical form in which most fats exist in the human body and in foods. The "tri" means three, in this case three fatty acids.  "Glycerides" means derived from glycerol, a three carbon molecule.  Thus, a triglyceride is three fatty acids attached to one molecule of glycerol.  Triglycerides are the transport and storage form of fatty acids, which are insoluble in water environments such as blood and require specialized transport proteins, e.g, lipoproteins.  There are many different types of fatty acids, including "good" fatty acids such as unsaturated and cis types and "bad" fatty acids such as saturated and trans types.  Triglycerides (with their fatty acids) are stored in the fat cells of the body when calories are taken in in excess during meals.  They are broken down and released to body tissues for energy during periods of calorie deficiet. The release of these triglycerides from fat tissue for energy is regulated by the body’s hormones.

Dietary fat is hydrolyzed in the small intestine, absorbed and resynthesized by mucosal cells and secreted into lacteals (lymphatic capillaries) as chylomicrons. Triglycerides in the chylomicrons are cleared from the blood by tissue lipoprotein lipase. Endogenous triglyceride production occurs in the liver. These triglycerides are transported in association with lipoproteins in very low density lipoproteins (VLDL). If serum is clear, the serum triglyceride level is generally below 1000 mg/dL. Triglyceride levels >1000 mg/dL can lead to abdominal pain and be life-threatening due to acute pancreatitis.  Levels over 1000 mg/dL may be seen when a primary lipid disorder is exacerbated by alcohol or fat intake or by corticosteroid or estrogen therapy.

  • Diagnostically useful in conjunction with the lipid panel to identify individuals at risk for coronary heart disease (CHD)
  • As an aid in evaluation of nephrotic syndrome
  • As an aid in evaluation of fatty liver in chronic alcoholism
  • As an aid in evaluation of lipoproteinemia due to lipase deficiency
  • As an aid in evaluation of liver disease (hepatitis and liver cirrhosis)
  • As an aid in evaluation of biliary obstruction
  • As an aid in evaluation of diabetes
  • As an aid in evaluation of renal failure
  • As an aid in evaluation of metabolic abnormalities due to endocrine disorders

Increased in:

  • Familial hypertriglyceridemia
  • Hypertriglyceridemia, severe (type V)
  • Apolipoprotein C-II deficiency
  • Eruptive or planar xanthoma
  • Lipemia retinalis
  • Hypothyroidism
  • Diabetes mellitus
  • Nephrotic syndrome
  • Chronic alcoholism (fatty liver)
  • Biliary tract obstruction
  • Stress
  • Familial lipoprotein lipase deficiency
  • Familial dysbetalipoproteinemia
  • Familial combined hyperlipidemia
  • Obesity
  • Metabolic syndrome
  • Viral hepatitis
  • Biliary cirrhosis
  • Pancreatitis
  • Chronic renal failure
  • Gout
  • Pregnancy
  • Glycogen storage disease types I, III, and VI
  • Anorexia nervosa
  • Dietary excess
  • Cushing's syndrome
  • Severe infection and inflammation
  • Some drugs such as: beta-adrenergic blockers, cholestyramine, corticosteroids, diazepam, diuretics, estrogens, estrogen-containing oral contraceptives

Decreased in:

  • Tangier disease ( Familial alpha-lipoprotein deficiency)
  • Hypobetalipoproteinemia and abetalipoproteinemia
  • Malnutrition
  • Malabsorption
  • Parenchymal liver disease
  • Hyperthyroidism
  • Intestinal lymphangiectasia
  • Decreased in use of some drugs such as: ascorbic acid, clofibrate, nicotinic acid, gemfibrozil
Category mg/dL mmol/L
Normal <150 <1.70
Borderline high 150–199 1.70–2.25
High 200–499 2.26–5.64
Very high 500 5.65
Enzymatic, Colorimetric.

Serum (SST) or Plasma EDTA (Lavender).

Patient should be fasting 10-16 hrs prior to collection of specimen.
Patient should be fasting for 10-14 hours and avoid alcohol for 24 hours prior to specimen collection.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Lipid Panel with cardiac risk index, Hemoglobin A1C, Thyroid Stimulating Hormone, Liver Panel, Renal Panel, Comprehensive Metabolic Panel, Lipoprotein profile (NMR Lipoprotein profile).
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Curr Drug Targets. 2009 Apr;10(4):336-43. [PMID: 19355858]
  • Endocrinol Metab Clin North Am. 2009 Mar;38(1):137-49. [PMID: 19217516]
  • Am J Med Sci. 2005;330:295. [PMID: 16355014]
  • Curr Med Res Opin. 2005;21:665. [PMID: 15969866]
  • J Fam Pract.2006;55:S1. [PMID: 16822443]
  • Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).